As of April 15, 2025, Yuhan (000100.KS) has a market cap of $6.03 billion USD. According to our data, Yuhan is ranked No.2284 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $6.03 B |
-2.17%
|
Dec 30, 2024 | $6.17 B |
74.45%
|
Dec 28, 2023 | $3.54 B |
27.15%
|
Dec 29, 2022 | $2.78 B |
-2.60%
|
Dec 30, 2021 | $2.85 B |
-12.63%
|
Dec 30, 2020 | $3.27 B |
67.59%
|
Dec 30, 2019 | $1.95 B |
22.48%
|
Dec 28, 2018 | $1.59 B |
-1.01%
|
Dec 28, 2017 | $1.61 B |
16.34%
|
Dec 29, 2016 | $1.38 B |
-22.65%
|
Dec 30, 2015 | $1.79 B |
61.98%
|
Dec 30, 2014 | $1.10 B |
-8.43%
|
Dec 30, 2013 | $1.20 B |
8.96%
|
Dec 28, 2012 | $1.11 B |
36.66%
|
Dec 29, 2011 | $0.81 B |
-25.82%
|
Dec 30, 2010 | $1.09 B |
2.92%
|
Dec 30, 2009 | $1.06 B |
-15.05%
|
Dec 31, 2008 | $1.25 B |
13.79%
|
Dec 28, 2007 | $1.10 B |
19.75%
|
Dec 28, 2006 | $0.92 B |
2.68%
|
Dec 29, 2005 | $0.89 B |
119.63%
|
Dec 31, 2004 | $0.41 B |
28.32%
|
Dec 31, 2003 | $0.32 B |
30.64%
|
Dec 31, 2002 | $0.24 B |
-16.96%
|
Dec 31, 2001 | $0.29 B |
56.25%
|
Dec 29, 2000 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
Market Cap | = | 000100.KS Stock Price | * | 000100.KS Shares Outstanding |
= | $80.64 | * | 73.79 M | |
= | $6.03 B |